良性前列腺增生癥(參考版)
2024-11-04 02:46本頁面
【正文】 ,。ir243。,Thanks for your attention !,第三十七頁，共三十八頁。,第三十五頁，共三十八頁。,臨床診斷：主要以典型病史、體征、B超等為主，思維培養(yǎng)和形成是重點。,體征：直腸指診非常(fēich225。i ni224。n)：老齡和有功能的睪丸。o ti225。,總 結,發(fā)病的必要條件(b236。o)目的是評估療效、確定治療的依從性、盡早發(fā)現(xiàn)與治療相關的副作用或并發(fā)癥，并提出解決方案，同時監(jiān)測前列腺癌的發(fā)生。,BPH各種治療后都應進行隨訪。uguǎn)，定期更換，維持引流尿液通暢。,第三十二頁，共三十八頁。b236。b236。,手術(shǒush249。,2 開放手術(shǒush249。o)的首選方法。,1 經(jīng)尿道前列腺切除術〔TURP〕 具有效果好，創(chuàng)傷小，患者恢復快等特點，是前列腺增生手術治療(zh236。)方案選擇,可用于一般情況較差，不能耐受手術或不愿接受(jiēsh242。,一般手術(shǒush249。 有嚴重心、肺、肝、腎功能不全者，先通過留置導尿管或恥骨上膀胱造瘺術引流尿液，待情況好轉后再行手術。,三 手術治療 手術指證： 1 重度BPH的下尿路病癥已明顯影響患者生活質量； 2 當BPH導致以下并發(fā)癥時：反復尿潴留；反復血尿；反復泌尿系感染；膀胱結石；繼發(fā)性上尿路積水〔伴或不伴腎功能損害〕。,The 2022 AUA guidelines on the management of BPH recommend 5ARIs (5 mg finasteride，0.5 mg dutasteride daily) as a monotherapy or combined treatment for BPH based on the Medical Therapy of Prostatic Symptoms and Combination of Avodart and Tamsulosin Trials.,The 2022 EAU guidelines recommend 5ARIs for LUTS with benign prostatic obstruction . They recommended that 5ARIs should be offered to men who have moderate to severe LUTS，prostate size≥40g，and a PSA level＞1.4–1.6g/L，and they indicated that 5ARIs can prevent progression and the need for prostate surgery .,The NICE in the UK developed the NICE guidelines for highquality healthcare and encouraged healthy living based on the evidence. The NICE guidelines for LUTS，which are shown in a detail in，recommend 5ARIs for men with LUTS who have a prostate size≥30g，PSA≥1.4ng/mL，and a risk for progression. Combination therapy with an alpha blocker can
教學課件相關推薦
鄂ICP備17016276號-1